HUGE Breakout Play Coming in 26hrs! Don�t Miss Out
OTCtipReporter Newsletter
URGENT REMINDER: My “Past-Performer” KaBOOM Breakout Play Coming Thursday the 22nd at 9:30AM EST! URGENT REMINDER: We have a HUGE NEW ALERT Ready to Go! I wanted to send out a quick reminder that I will be announcing My “Past-Performer” KaBOOM Breakout Play (Thursday) the 22nd at 9:30 AM EST! For anyone that may have missed my email from earlier, I`ve included a copy of our alert below.
————————————————————— HUGE New Pick Coming Thursday 9:30 AM Est Could Be Best Opportunity Ever! Dear Fellow Trader, Everyone is asking us for our next pick, Well it`s going to shock you! Wait until you see what I`ve just uncovered! After researching some potential gainers, I uncovered what could be a “Huge Trade Opportunity” which I am introducing (Thursday) the 22nd at 9:30 AM EST! Note: This is a recent pick that we are dubbing Thursday`s “Past-Performer” KaBOOM Breakout Play!! After further due diligence, I believe that I am more than convinced that our “Past-Performer” is poised for MASSIVE GAINS once again!! This pick has been known for explosive Gains, it rocketed up and more than doubled the last time I profiled it!! Fact #1: The last time that I released this pick it shot up and more than (doubled) in price! Fact #2: The stock did not spike in the AM and immediately retrace in the afternoon – it continued to climb into the following day`s trading session.
Here`s What You Must Do Next to Get My “Past-Performer” KaBOOM Play Scheduled for Thursday the 22nd at 9:30 AM EST! **You must reply back to this email if you want my “Past-Performer” KaBOOM Breakout Play!!!**
Step 1: Reply back to this Email Immediately! Step 2: The subject line must be (Want “Past-Performer” KaBOOM Breakout Play) To receive my alerts first before the crowd you have to take the action to request it. By taking these two actions steps you will be (locked in) to get my next pick scheduled to hit your inbox Thursday the 22nd at 9:30 AM EST! Make sure you are watching your inbox, this recent “Past-Performer” Breakout Play, could be a huge winner for everyone.
So be on High Alert and Ready to Act! Happy Traing! The OTCtipReporter Team The Company`s September 2013 announcement regarding its investment in the World Trade Center Cologne ( The Company forecasts a very positive 4th quarter for 2013 and anticipates securing more than US $100M in assets during the 2014 calendar year by acquiring new businesses and/or companies that meet its investment guidelines.
About American First Financial Inc.
American First Financial Inc. is an international investment company with a focus on developing and marketing its own products.
The management`s network and the general orientation of the Company`s investments provide a significant competitive advantage.
American First Financial creates tailored solutions and financing for its projects and investments so each client`s unique financial needs are met. American First Financial focuses on companies with a strong and profitable business model and includes start-ups as well as already established companies worldwide. The company`s goal is the building of a portfolio of successful and profitable investments. The financial sector of American First Financial Inc.
is framed by such companies as Neue Medien Gruppe GmbH., a provider of payment services; Bizzvest Holding & Investment Group Corp., which specializes in corporate and startup financing; and the Kennedy Capital Real Estate Finance Corp., which deals with Tax Deed and Tax Certificate financing as well as real estate in the United States. The company combines classic and innovative business models to create sustainable long-term profitability and success-oriented work.
If you haven`t taken a look at AFRS yet, this may be the last chance in this range! Start your research immediately! As always we encourage subscribers to do their own due diligence and visit the company website: www.afrs-financial.com Happy Trading!! The OTCtipReporter Team P.S. Remember what I always say… book profits when you are in a position to do so, and always trade with stop loss orders to protect yourself if the trade goes against us.
DONT MISS ANOTHER HOT OPPORTUNITY TO MAKE HUGE PROFITS! GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCtipReporter.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on OTCtipReporter.com or mentioned herein.
Affiliates, officers, directors and employees of OTCtipReporter.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value.
OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions.
These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section-27(a) of the U.S. Securities Act-of-1933 and Section 21(e) of the U.S.
Securities Exchange Act-of -934. Neither OTCtipReporter.com, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results. The information contained herein contains “forward-looking statements,” within the meaning of Section-27A of the Securities Act-of-1933 and Section 21E of the Securities Exchange Act-of-1934.
Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein.
More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.
Buying and Selling of Shares OTCtipReporter.com intends to sell its shares. OTCtipReporter.com may sell its shares for less than target prices given in opinions.
OTCtipReporter.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value.
OTCtipReporter.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on OTCtipReporter.com. If at any time you wish to be removed from our list simply
Related posts:
- Our HUGE Success Continues!
- $1 Trillion Dollar Opportunity
- Merry Christmas!!! HUGE New Breakout Play Coming Thursday!
- SOFT – Getting Ready to Breakout Big!
- HKTU – Getting Ready for Round Two! Updates inside